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In vivo induction of interleukin-1 during hemodialysis. In vivo induc-
tion of interleukin-1 (IL-i) production during hemodialysis was inves-
tigated by measuring IL-I activity in monocyte lysates from 59 patients
undergoing long-term maintenance hemodialysis with complement ac-
tivating and non-complement activating devices. In patients dialyzed
with new hollow-fiber cuprophane dialyzers, predialytic (TO) monocyte-
associated IL-i activity was 12.5 3.0 U/ml (mean SEM), a value that
was higher than that found in normal individuals (2.85 0.85 U/mi; P
<0.0025) and in non-dialyzed patients with chronic renal failure (0.95
0.85 U/ml, P < 0.0001). Cell-associated IL-i activity was consistently
increased after five hours of dialysis with cuprophane membranes (42.4
5.5 U/mI, P < 0.0005). Systemic complement activation was demon-
strated by the finding of increased plasma levels of C3adesArg antigen
during dialysis. In patients dialyzed with high permeability polyacrylo-
nitrile and polysulfone membranes, no intradialytic change in cell-
associated IL-i and no complement activation occurred. However, the
mean predialytic values of monocyte-associated IL-I in these patients
(that is, 32.9 5.6 U/mI and 38 5.65 U/mI for the polyacrylonitrile
and the polysulfone groups, respectively) were higher than the predialy-
tic levels of cell-associated IL-I in the patients from the cuprophane
group (P < 0.0025). Monocytes obtained at the beginning and five hours
of dialysis from patients dialyzed with polyacryionitrile devices, and
monocytes obtained at five hours but not at the beginning of dialysis
from patients dialyzed with cuprophane membranes, spontaneously
released extracellular IL-I after 24 hours of culture in serum free
conditions. Neither polyacrylonitrile nor cuprophane differed in their
capacity to stimulate monocytes that had adhered to the membrane, to
produce IL-l in serum free cultures. These results indicate that IL-I is
transiently generated during hemodialysis with complement activating
membranes when C3aiC3adesArg and CsaiC5adesArg, which are
known inducers of IL-i production, are generated in plasma. Non-
complement dependent factors, possibly LPS or fragments of LPS that
often contaminate bicarbonate dialysates, may be responsible for
chronic stimulation of IL- 1 production in patients dialyzed with high
permeability membranes.
lation of the anaphylatoxins C3a and CSa and of their stable
plasma desArg derivatives C3adesArg and C5adesArg [3, 7].
C5a and C5adesArg are directly involved in the pathogenesis of
the transient dialysis leukopenia, which is mediated by in-
creased expression of the adhesive membrane protein Mol
(CD1 ib) on granulocytes [8] and sequestration of activated cells
in the pulmonary vasculature [9, 10]. Little or no complement
activation and no leukopenia is observed in patients dialyzed
with plate polyacrylonitrile devices [3, 11]. Intravascular com-
plement activation and/or generation of other inflammatory
mediators may also be responsible for certain long-term clinical
sequelae in patients on maintenance hemodialysis [2, 12]. A
critical mediator in this respect could be interleukin-1 (IL-i).
IL-i represents a family of polypeptides primarily derived from
stimulated mononuclear phagocytes [13]. Endotoxins (LPS)
[14] and their polysaccharidic moieties [15], human C5a,
C5adesArg [16, 17], C3a/C3adesArg [171 and a number of other
substances that could be relevant to hemodialysis [18] induce
monocytes to produce IL-I in vitro after a brief exposure
period.
The present study demonstrates that IL-i is transiently and
consistently generated in vivo during hemodialysis with com-
plement-activating cuprophane membranes; we also report that
monocytes from patients dialyzed with complement-biocompat-
ible polyacrylonitrile and polysuifone membranes are chroni-
cally stimulated to produce IL- 1, although in most patients no
intradialytic increase in IL-i production is observed.
Methods
Study population
An increasing interest is devoted to the understanding of the
deleterious consequences of blood/membrane interactions in
extracorporeal devices [1]. Complement activation which oc-
curs during hemodialysis [2] is determined by the type of
dialysis membrane [3—5], whether it is new or re-used [6], and
by unidentified individual factors [7]. Complement activation
consistently occurs in patients dialyzed with new cuprophane
hollow-fiber dialyzers, which results in generation in the circu-
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Fifty-nine long-term chronic hemodialysis patients undergo-
ing five hours of maintenance hemodialysis three times a week
in the same outpatient dialysis center were chosen for the
study. Informed consent was obtained. Patients included 31
men and 28 women ranging in age from 16 to 72 years (mean
age: 37.3). The original nephropathy was chronic glomerulone-
phritis (31 patients), interstitial nephritis (17 patients), nephro-
angiosclerosis (2 patients), polycystic kidney disease (2 pa-
tients) or undetermined (7 patients). All patients had been on
maintenance hemodialysis for more than 12 months and had
been dialyzed using the same type of membrane for over two
months at the time of the study. Twenty-one patients were
undergoing hemodialysis with new cuprophane hollow-fiber
dialyzers (Hemofrance, l'Arbresle, France; Gambro, Lund,
Sweden; Fresenius, Bad Homburg, FRG); 22 patients were
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dialyzed with polyacrylonitrile sheet membrane devices (AN69,
Hospal, Lyon, France); 16 patients were dialyzed with polysul-
fone fiber dialyzers (Fresenius F50 and F60). Bicarbonate
dialysate (Pharmacie Centrale des Hôpitaux de Paris, Paris,
France) was used in all patients. The endotoxin content of the
dialysates used at the time of the study has not been deter-
mined. However, the same batches of concentrate were used in
patients dialyzed with Cuprophane and in patients dialyzed with
high permeability membranes. When tested at monthly inter-
vals for one year, the endotoxin content in bicarbonate concen-
trates ranged from 2.5 to 270.0 EU/mI and that in the treated
water ranged from 0—10 EU/mi, as assessed using a commercial
colorimetric Limuius Amebocyte Lysate assay (Wittaber,
Walkersville, Massachusetts, USA).
Control subjects were 14 healthy members of the medical
staff (age 20 to 50) and 10 non-hemodialyzed patients with
chronic renal failure (age 39 to 75; serum creatinine 440 to 1200
jmol/liter) including six patients with chronic glomerulonephri-
tis, three patients with nephroangiosclerosis and one patient
with interstitial nephritis.
Preparation of peripheral blood monocytes and IL-I assays
Heparinized blood was obtained predialysis from the pa-
tients' arteriovenous fistula and subsequent samples were ob-
tained from the efferent line of the dialyzer during the dialysis
session. Peripheral blood mononuclear cells were separated
from whole blood by centrifugation on MSL (Eurobio, Paris,
France). Monocytes were identified by staining with non-
specific esterase (NSE) using alphanaphtyl acetate as substrate
[19]. Mononuclear cells were enriched in monocytes by allow-
ing the cells to adhere to 24-well plastic cultured dishes (Nunc,
Röskilde, Denmark) in the absence of serum for 45 minutes.
Five hundred microliters of RPM! 1640 (MA Bioproduct) con-
taining 5 x iO NSE-positive cells were plated in each well.
After two vigorous washes with RPM! 1640 containing 100 IU/
ml penicillin and 100 g/ml streptomycin, mononuclear adher-
ent cells were lyzed by three freeze-thaw cycles at —80°C in 0.5
ml RPM! containing antibiotics to extract cell-associated (mono-
cyte-associated) IL-i, as described [20—22]. Under these con-
ditions, the adherent cells contained more than 85% monocytes,
as assessed by morphological analysis by phase contrast mi-
croscopy, staining with NSE and indirect immunofluorescence
using anti-lymphocyte antibodies OKT1 1 (Ortho Diagnostics,
Raritan, New Jersey, USA) and IOBI (Immunotech, Marseille,
France). After centrifugation of the monocyte lysates at 2000 x
g for 10 minutes at 4°C, IL-I activity was measured in the
supernatants by means of a conventional ConA comitogenic
assay using C3H/HeJ thymocytes [15]. The freeze-thawing
procedure yielded reproducible results since the SD of the mean
cell-associated IL-i activity measured in eight lysates of normal
LPS-stimulated monocytes (10 tg of Neisseria meningitidis
[Nm] LPS/5 x 1O5 cells) did not exceed 10% (795 U/mI 61).
Units of IL-i activity/mi of culture supernatant were calculated
as follows:
U/mi = cpm of test sample — background cpm
x dilution of test sample
where cpm of test sample is the mean of (3H)-thymidine
incorporated in triplicate cultures of thymocytes performed in
the presence of supernatants from monocyte cultures. Back-
ground cpm is (3H)-thymidine incorporated in thymocytes
cultured in RPM! alone.
Each assay of IL-i activity included cultures performed in
the presence of a constant source of monocyte-associated IL-I
obtained by stimulation of monocytes of one individual with 10
p.g/5 X i05 cells of Nm LPS as the internal standard. The
internal standard contained 1000 U/mi of thymocyte- stimulating
activity and 2.2 ng/ml of IL-i beta antigen as determined using
a commercial radioimmunoassay.
In additional experiments, monocytes from five patients
dialyzed with cuprophane membranes and five patients dialyzed
with a polyacrylonitrile membrane were cultured in the absence
of serum (5 x i05 NSE cells in 0.5 ml RPM! containing
antibiotics/well) for 24 hours at 37°C in the presence of 5% CO2.
After centrifugation, IL-i activity released in the supernatants
was assayed on inurine thymocytes. RPM! contained no detect-
able LPS as assessed using the Limulus assay.
Complement assays
For measurement of plasma concentrations of C3adesArg
antigen, blood was obtained at times 0, 15 minutes and 5 hours
of dialysis in tubes containing ethylenediamine tetraacetate
(EDTA, 5 mii final). Samples were immediately centrifuged at
4°C and the plasma was stored at —80°C until processing.
C3adesArg antigen levels were determined using the radioim-
munoassay developed by Upjohn (Upjohn Co, Kalamazoo,
Michigan, USA) [231.
Statistics
All grouped data are reported as means SEM. Statistical
analysis was performed with Student's 1-test.
Materials
LPS from Neisseria meningitidis was from Dr. D. Schultz,
Institut Mérieux, Lyon, France. Rabbit anti-human IL-i anti-
serum was obtained from Genzyme (Genzyme Corp., Boston,
Massachusetts, USA). The radioimmunoassay for IL-I beta
was from Cistron Biotechnology, Pine Brook, New Jersey,
USA. For in vitro experiments investigating the ability of
dialysis membranes to trigger monocyte production of IL-i,
small sterile dishes of Cuprophane and polyacrylonitrile (from
C. Pusineri, Hospal, Lyon, France) were used. The diameter of
the disc was that of a culture well of 24-well plastic cultures
dishes.
Results
Monocyte-associated IL-i activity was measured at the be-
ginning and after five hours of hemodialysis in patients under-
going hemodialysis with first use cuprophane, polyacrylonitrile
and polysuifone membranes. At the beginning of the session
(TO), the mean monocyte-associated IL-i activity in 21 patients
undergoing dialysis with cuprophane membranes was 12.5
3.0 U/mI, a number which was higher than that measured in 14
healthy individuals (2.85 0.85 U/mI; P < 0,0025) and in 10
non-dialyzed patients with chronic renal failure (0.95 0.85; P
< 0.0001). After five hours of hemodialysis, monocyte-asso-
ciate IL-i activity increased in 16 of2l patients to reach a mean
background cpm
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Fig. 1. Cell-associated IL-i activity in
monocytes from chronic hemodialysis patients
undergoing hemodialysis with first use,
cuprophane hollow-fiber dialyzers (A),
poivacrylonitrile plate dialyzers (B) and
polysulfone hollow-fiber dialyzers (C). Results
are expressed in units of IL-l activity/mi as
defined in Methods.
value of 42.4 5.53 U/mi (P < 0.0005, Fig. 1). The mean
monocyte count in these patients decreased by 21.3 4%
(mean SEM) at the end of dialysis as compared with predial-
ysis counts. In 22 patients undergoing hemodialysis with poiy-
acrylonitrile membranes, a high value of monocyte-associated
IL-I activity of 32.9 5.6 U/mI was found at TO. The latter
value was significantly different from that observed at TO in the
group of patients dialyzed with cuprophane dialyzers (P <
0.0025) and from that measured in healthy individuals (P <
0.0005) and in non-dialyzed patients with chronic renal failure
(P < 0.0005). After five hours of dialysis (T5h) with polyacry-
lonitrile membranes, monocyte-associated IL-I activity in-
creased in 5 of 22 patients, whereas it decreased or remained at
predialysis levels in the majority of the patients. Mean mono-
cyte-associated IL-l activity at T5h was 59.2 7.0 U/mi, which
represented an increase over predialysis values (P < 0.01). In
16 patients dialyzed with polysulfone fibers, the mean value of
monocyte-associated IL-i activity was 38 5.65 U/mI at TO,
which was significantly higher than in the cuprophane group at
TO (P < 0.0025). It was 36.5 6.7 U/mI after T5h of hemodi-
alysis, a value that was not different from that measured at TO
in this group of patients.
Monocyte-associated IL-i activity that was detected in cell
lysates using the thymocyte proliferation assay was inhibited in
a dose-dependent manner by polyclonal anti-IL-i antibodies
when used at a 1/50 to a 1/500 dilution. The ratio between IL-i
activity and concentrations of IL-i beta antigen in cell lysates
from patients' monocytes was similar to that between IL-I
activity and IL-l beta antigen in cell lysates from normal
monocytes stimulated with LPS.
To examine whether low predialytic levels of cell-associated
IL- 1 in patients dialyzed with cupropharie membranes were due
to the presence of (a) circulating IL-I inhibitor(s) that would not
be dialyzed with low molecular weight cut-off membranes,
various amounts of lyzates from monocytes obtained at TO from
three patients in the cuprophane group were mixed with dilu-
tions of lyzates from normal LPS-stimulated monocytes that
yielded half maximal values for IL-I activity in the thymocyte
proliferation assay. No inhibition of IL-i activity was observed.
The kinetics of increase in monocyte-associated IL-i activity
in patients dialyzed with cuprophane dialyzers were studied in
five individuals. Two patients demonstrated increased values of
cell-associated IL-i as soon as two hours after the beginning of
dialysis. In four of five patients, monocyte-associated IL-i
increased by at least twofold at the end of dialysis (Fig. 2). As
shown in Table 1, the relative intradialytic increase in mono-
cyte-associated IL-I was similar when tested during repeated
dialysis sessions in a given patient.
Measurements of the plasma concentration of C3adesArg
antigen could be obtained in 13 of the patients undergoing
hemodialysis with cuprophane membranes and 10 of the pa-
tients dialyzed with polyacrylonitrile membranes. In patients
from the cuprophane group, C3adesArg levels increased from a
mean predialysis value of 170 S ng/ml to 1154 76 ng/ml in
the efferent sample at 15 minutes after dialysis (T15 mm; that is,
a 6.8-fold increase). C3adesArg levels decreased to 453 45 ng/
ml at the end of dialysis. In five patients in this group in whom
monocyte-associated IL-I was below 10 U/mI at TO, the relative
intradialytic increase in cell-associated IL-i was correlated with
the relative increase in C3adesArg levels between TO and T15
mm (r = 0.75). In patients dialyzed with polyacryionitrile
dialyzers, C3adesArg levels were 206 20 ng/ml at TO, 336
7.3 ng/ml at Tl5 mm (a 1.6-fold increase) and 258 26 nglml at
T5h.
In order to assess whether increased values of monocyte-
associated IL-I activity that were observed in hemodialyzed
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Fig. 2. Kinetics of increase in cell-associated IL-i activity in mono-
cytes from patients undergoing hemodialysis with first use, hollow-fiber
cuprophane dialyzers. Results are expressed as mean 3(H)-thymidine
cpm SD incorporated in triplicate thymocyte cultures. The dashed
line depicts 3(H)-thymidine incorporated by thymocytes cultured in the
absence of monocyte supernatants.
Table 1. Measurements of monocyte-associated IL-i activity in a
patient dialyzed with first use, cuprophane hollow-fiber devices
during 3 different hemodialysis sessions
Monocyte-associated IL-i activity
U/mi
TO T5h SI.
Dialysis on day 1 2.2 29 13.1
Dialysis on day 15 0 18.6 18.6
Dialysis on day 44 0 22 22.0
patients may reflect IL-I activity that could be further released
in plasma in vivo, monocytes were isolated from blood samples
obtained at TO and T5h of hemodialysis, and cultured for 24
hours in the absence of serum. Spontaneous release of IL-i
activity in the culture supernatant was then assessed. Little or
no IL-i activity (mean = 0.12 0.11 U/mI) was released by
cultured monocytes that had been obtained at TO from five
patients dialyzed with cuprophane membranes who were
tested. A mean of 9.9 2.51 U/mI of IL-i activity was released
by cultured monocytes that had been obtained from these
patients after five hours of hemodialysis (Table 2). In contrast,
high amounts (mean = 25.3 11.61 U/mi) of spontaneously
released IL-l were found in supernatants of cultured monocytes
that had been obtained at TO from five patients dialyzed with
polyacrylonitrile devices. Spontaneously released IL- 1 in-
creased only twofold after five hours of hemodialysis in these
patients (mean = 22.1 U/ml). Monocytes from 14 normal donors
cultured for 24 hours under the same conditions in the presence
of 1 g/ml of Nm LPS, released a mean IL-i activity of 155 U/
ml (30 to 330 U/mI).
To investigate whether the dialysis membranes may directly
trigger synthesis of IL-I in monocytes, monocytes (5 x l0/
well) from four normal individuals were allowed to adhere for
45 minutes to plastic culture dishes or to wells that had been
pre-coated with cuprophane or polyacrylonitrile, and further
cultured for five hours in serum-free conditions. The number of
NSE trypsin-detachable cells that had adhered to the surfaces
were 6.09 x lO, 5.10 x iO and 5.64 X iO cells/well for control
plastic culture dishes, cuprophane and polyacrylonitrile, re-
spectively. The 45-minute adherence period was insufficient to
trigger IL-i synthesis by cells in contact with any of the
surfaces, as assessed by measuring cell-associated IL- 1 activity
(Fig. 3). During the five-hour culture period, a time-dependent
stimulation of IL-i synthesis was observed on monocytes
cultured on plastic dishes in the absence of serum. No differ-
ence in the amount of cell-associated IL-i activity that was
produced was found between cells cultured on plastic and cells
cultured either on cuprophane or on polyacrylonitrile. No
significant adsorption capacity for IL-I of cuprophane and
polyacrylonitrile membranes was found in control experiments
in which a source of cell-associated IL-i was incubated in wells
that had been precoated with the membranes for five hours at
22°C.
Discussion
Interleukin-i (IL-i) is a critical mediator of the inflammatory
reaction that induces a wide range of biological effects at the
site of inflammation and in distant organ targets [13, 18]. LPS
[14, 181 and the complement-derived fragments C3adesArg and
C5adesArg [16, 171 induce production of IL-l and IL-l release
from human monocytes. IL-i is not preformed in unstimulated
cells [21, 241. After stimulation with LPS, cytoplasmic pro IL- 1
mRNA can be detected within two hours in vitro [25]. Intracel-
lular protein and IL-i activity parallel the IL-l message level
[25]. Cell-associated IL-i activity preceeds by at least four
hours the release of IL-I in culture supernatants [26, 271. Some
of the adverse effects that may follow exposure of whole blood
to dialysis membranes, including fever, hypotension [i2] and,
possibly, the late occurrence of amyloidosis have been sug-
gested to be mediated by IL-l. The present study provides
direct evidence for enhanced production of IL-i in hemo-
dialyzed patients.
We investigated monocyte-associated IL-l activity rather
than circulating IL-i for the following reasons: 1) the presence
in human plasma of IL-i inhibitors [28] and of factors that may
interfere with the thymocyte proliferative assay for IL-i activ-
ity (29); the unlikelihood of generation of detectable amounts of
released IL-l in plasma during the five hours of hemodialysis.
Thus, IL-l activity is found in cell lysates after five hours of
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Abbreviations are: TO, beginning of dialysis; TSh, five hours of
dialysis, S.I., stimulation index. The units for TO were standardized to
1.0.
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Table 2. Spontaneous IL-i release by cultured monocytes from patients undergoing hemodialysis
Patient
number
Dialysis
membrane
Released IL-i activity U/mi
TO T5h
I Cuprophane 0 13.4 2.O
2 Cuprophane 0 15.6 2.6
3 Cuprophane 0.6 9.1 2.6
4 Cuprophane 0 0
5 Cuprophane 0 11.4 0.8
Mean SEM 0.12 0.11 9.9 2.51 P = 1 x iO
6 Polyacrylonitrile 25 2.7 34.2 4.8
7 Polyacrylonitrile 1.9 0.2 34.3 4.2
8 Polyacrylonitrile 69 10.3 71 9.6
9 Polyacrylonitrile 11.5 1.3 41 5.6
10 Polyacrylonitrile 19.1 2.6 30.8 4.6
Mean SEM 25.3 11.61 42.2 5.20 NS
Monocytes isolated from blood samples obtained at TO and T5h of hemodialysis were cultured (5 x iO NSE cells in 0.5 ml RPMiJwell) for 24
hours in the absence of serum. IL-l activity spontaneously released in the supernatant of cell cultures was measured as described in Methods.
Results are expressed in units of IL-i activity/mi of culture supernatant.
a Mean SD lfl triplicate cultures.
b Student's t-test. NS is non-significant.
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Fig. 3. Kinetics of increase in cell-associated IL-I
activity in monocytes from 4 norma! individuals cultured
in the absence of serum in plastic culture dishes (A), in
wells coated with cuprophane (B) and wells coated with
polyacrylonitrile (C). Results are expressed as mean IL-
1 U/mI SEM.
culture of monocytes in the presence of low amounts of LPS or
C3adesArg. Within the same period of culture, less IL-i activity
is released extracellularly from monocytes stimulated with LPS
and no IL-i activity is detected in supernatants of cultures
containing C3adesArg [17].
At the beginning of dialysis (TO), low levels of monocyte-
associated IL-I activity were found in all patients undergoing
maintenance hemodialysis with new hollow-fiber cuprophane
dialyzers. The mean value of cell-associated IL-i in these
patients was higher than that which was measured in monocytes
from 14 normal individuals and from 10 non-dialyzed patients
with chronic renal failure. High amounts of monocyte-associ-
ated IL- 1, equivalent to 20% of the amount that is found in
normal monocytes cultured for five hours in the presence of 1
p.g/ml Nm LPS, were found at TO in patients dialyzed with
polyacrylonitrile and with polysulfone devices. Monocytes at
TO of polyacrylonitrile dialysis were not maximally stimulated
since the cells could further be triggered in vitro if cultured in
the presence of exogenous LPS (data not shown). Taken
together, these observations suggest that, three days after a
dialysis session, monocytes from patients dialyzed with high
permeability membranes were stimulated in vivo to produce
IL-i. Furthermore, no IL-i was found to be released from
monocytes obtained at TO from five patients dialyzed with
cuprophane membranes and cultured for 24 hours in the ab-
sence of serum and exogenous stimulus, whereas monocytes
obtained at TO from five patients in the polyacrylonitrile group
released significant amounts of IL-i under similar culture
conditions. In both groups of patients, plasma concentrations of
C3adesArg antigen at TO were within the limit of normals. The
nature of the complement-independent IL-i inducer that stim-
ulates monocytes in vivo in patients undergoing hemodialysis
with high permeability non-complement activating membranes
is unknown at the present time. One possible explanation would
be the passage of rough LPS and/or fragments of LPS with
molecular weights between 2800 and 4800 daltons [30] through
polyacrylonitrile and polysulfone membranes. Preliminary re-
sults from recently performed experiments indicate that radio-
labeled Nm LPS may cross polyacrylonitrile membranes in
vitro [31]. Cultured monocytes that have been in contact with
LPS for five hours continue to produce cell-associated IL-i 72
hours after removal of the stimulus (unpublished observations).
Intravenously injected LPS may persist for several days in the
circulation in experimental animals [32]. Low amounts of
cell-associated IL-i found at TO in the cuprophane group could
represent residual IL-I from the previous dialysis session or
IL-i induced by other factors than intact LPS, of which no
passage has been observed through cuprophane membranes
[33—35]. Neither polyacrylonitrile nor cuprophane were found
to differ in their capacity to directly stimulate monocytes that
had adhered to these membranes to produce IL-i serum free
cultures in vitro.
In patients undergoing hemodialysis with new cuprophane
hollow-fiber dialyzers, monocyte-associated IL-i was signifi-
cantly increased at the end of dialysis as compared with values
obtained at TO. Similar results were obtained in five patients
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dialyzed with cuprophane flat sheet devices (data not shown).
The half life of monocytes exceeds 24 hours [36], suggesting
that monocytes which were found to produce IL-l at the end of
dialysis were representative of the monocyte population circu-
lating at the beginning of the session. Significant amounts of
IL-i were spontaneously released in supernatants of serum-free
24 hour cultures of monocytes obtained from cuprophane
patients at the end of the dialysis session, although the cells
could further be stimulated by addition of LPS to the cultures
(data not shown). The amount of IL-i that was spontaneously
released by monocytes under these conditions represented
approximately 10 to 20% of that which would be released by
monocytes from normal individuals in the presence of 1 gIml
Nm LPS in serum free conditions. Release of IL-i by unstim-
ulated cultured monocytes from the patients may be an indirect
indication that IL-i may be released in vivo in the hours
following the end of the dialysis procedure, the time at which
fever occurs in hemodialyzed patients. Complement activation
may be directly involved in triggering the intradialytic increase
of IL-i production that was observed with cuprophane mem-
branes. C3a was generated during dialysis in all patients from
the cuprophane group. A correlation was found between intra-
dialytic increases in IL-l production and C3adesArg levels in
patients in whom amounts of cell-associated IL-i were low at
TO. The latter correlation was not found if all patients from the
cuprophane group were considered, which may be due to the
differences that exist between individuals in their ability to
produce IL-i upon stimulation with anaphylatoxins [16, 17].
Multiple factors may determine the actual extent of comple-
ment-dependent IL- 1 production during cuprophane hemodial-
ysis, including: the amount of C3alC3adesArg produced, which
depends on individual responses to cellulose [7, 371; the relative
efficiency of C5a versus C3a production during complement
activation [38]; the individual monocytic response to C3a1
C3adesArg [17] and C3a/C3adesArg [161; and the putative
presence of IL-i inhibitors of monocytic origin [29] released in
response to activated complement. In contrast, no intradialytic
increase in IL-l production was found in most patients under-
going dialysis with polyacrylonitrile and with polysulfone mem-
branes in whom no complement activation occurred during
dialysis. C3a'C3adesArg induces IL-l production from mono-
cytes in vitro at concentrations equivalent to those found in the
plasma of patients dialyzed with cuprophane membranes [171.
In addition, elevated levels of C3a may be an indirect indication
of in vivo generation of C5a, which also triggers monocytes to
produce IL-i [16, 17]. Thus, transient activation of complement
in the cuprophane group may provide a mechanism for initiating
the transient stimulation of IL-l production in the patients.
The demonstration of increased IL-i production is another
example of the adverse effects that may occur during hemodi-
alysis 139]. Transient IL-l production occurs in patients dia-
lyzed with complement activating membranes. In patients dia-
lyzed with high-permeability polyacrylonitrile and polysulfone
devices, biocompatibility of the membrane for the complement
system appears to be counter-balanced, at least in some pa-
tients, by chronic stimulation of IL-I production. The long-term
effects of intermittent and chronic stimulation of IL-i produc-
tion in hemodialyzed patients remain to be established.
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